Literature DB >> 1349866

CD11b-bearing mononuclear leucocytes and IgA levels in the staging of human immunodeficiency virus infection.

J M Rivera-Guzmán1, J R Regueiro, J Alcamí, A Arnaiz-Villena.   

Abstract

Certain immunological parameters (i.e. low CD4+ T cell numbers, high serum soluble CD8) have been described as prognostic factors for the progression of human immunodeficiency virus (HIV) infection to later clinical stages. In the present study we have found in one hundred HIV-infected Spanish patients (81% drug abusers, 7% homosexuals, 6% heterosexuals, and 6% other or unknown risk groups) that CD11b+ peripheral blood mononuclear cells are increased in those with persistent lymphadenopathy as compared to other clinical stages (asymptomatic, AIDS-related complex and AIDS). Serum IgA was significantly increased in AIDS patients, and in patients at any other clinical stage who had concomitant infections (mainly mycobacterial and fungal). CD11b (an integrin with complement receptor functions) may thus be of clinical interest for the staging of HIV-infected patients, and reflect stage-selective immunological changes in mononuclear cell biology during HIV infection. High IgA on the other hand, would be a marker of concomitant infection as well as of disease progression. The results concern mostly drug addicts (the main risk group in Spain), but may apply to the other risk groups because no significant differences were detected between drug addicts (n = 81) and non-drug addicts (n = 19) for the studied variables (p greater than 0.05).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1349866     DOI: 10.1007/bf01923442

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  7 in total

1.  Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome.

Authors:  G Poli; M Introna; F Zanaboni; G Peri; M Carbonari; F Aiuti; A Lazzarin; M Moroni; A Mantovani
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

2.  Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1986-05-23       Impact factor: 17.586

3.  Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men.

Authors:  B F Polk; R Fox; R Brookmeyer; S Kanchanaraksa; R Kaslow; B Visscher; C Rinaldo; J Phair
Journal:  N Engl J Med       Date:  1987-01-08       Impact factor: 91.245

4.  Decreased oxidative burst activity of monocytes from asymptomatic HIV-infected individuals.

Authors:  G T Spear; H A Kessler; L Rothberg; J Phair; A L Landay
Journal:  Clin Immunol Immunopathol       Date:  1990-02

5.  Change in expression of Fc gamma RIII (CD16) on neutrophils from human immunodeficiency virus-infected individuals.

Authors:  P Boros; E Gardos; G J Bekesi; J C Unkeless
Journal:  Clin Immunol Immunopathol       Date:  1990-02

6.  Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type 1.

Authors:  E N Janoff; J M Douglas; M Gabriel; M J Blaser; A J Davidson; D L Cohn; F N Judson
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

7.  The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

Authors:  J L Fahey; J M Taylor; R Detels; B Hofmann; R Melmed; P Nishanian; J V Giorgi
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.